Acetato de ulipristal en el diagnóstico diferencial de carcinoma de endometrio

  • Baquedano Mainar L
  • Del Tiempo Marqués P
  • Adiego Calvo I
  • et al.
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Uterine fibroids are the most common genital tumors and the most common treatment is surgery. Actually there is an effective medical treatment to reduce its volume and the symptoms. It is ulipristal acetate (UA), a selective progesterone receptor modulator. In the endometrium it can cause some peculiar histological changes. We present a patient with symptomatic uterine fibroid with UA, and it was difficult to make differential diagnosis with endometrial cancer.

Cite

CITATION STYLE

APA

Baquedano Mainar, L., Del Tiempo Marqués, P., Adiego Calvo, I., Villalobos Salguero, F., Rubio Cuesta, P., Gimeno, E., & Ruiz Conde, M. A. (2016). Acetato de ulipristal en el diagnóstico diferencial de carcinoma de endometrio. Revista Chilena de Obstetricia y Ginecología, 81(2), 113–116. https://doi.org/10.4067/s0717-75262016000200005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free